Jones Financial Companies’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06K Hold
181
﹤0.01% 4595
2026
Q1
$664 Hold
181
﹤0.01% 4445
2025
Q4
$757 Hold
181
﹤0.01% 4082
2025
Q3
$635 Hold
181
﹤0.01% 3991
2025
Q2
$257 Buy
+181
New +$257 ﹤0.01% 3887
2023
Q4
Sell
-13
Closed -$18 1030
2023
Q3
$18 Hold
13
﹤0.01% 688
2023
Q2
$15 Hold
13
﹤0.01% 527
2023
Q1
$14 Hold
13
﹤0.01% 565
2022
Q4
$0 Hold
13
﹤0.01% 760
2022
Q3
$0 Hold
13
﹤0.01% 687
2022
Q2
$0 Buy
+13
New +$19 ﹤0.01% 816

Other funds holding PGEN

Jones Financial Companies's PGEN Position: Q2 2026 in Review

Jones Financial Companies held its Precigen (PGEN) position steady in Q2 2026 at 181 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #4595.

Jones Financial Companies first reported a position in PGEN in Q2 2022 and has held it in 11 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Jones Financial Companies held 181 shares of Precigen worth $1.06K as of Q2 2026.
  • Jones Financial Companies left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4595 holding.
  • Jones Financial Companies first reported a position in Precigen in Q2 2022 and has held it in 11 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.